4-氨基-3-(4-氟苯基)丁酸

4-氨基-3-(4-氟苯基)丁酸β-氨基甲基-4-氟苯丙酸(研发代号CGP-11130)是一种有机化合物,化学式为C10H12FNO2。它是GABAB受体激动剂,但从未上市。[1]它可由4-硝基-3-(4-氟苯基)丁醛经氧化至羧酸,再由硼氢化钠还原硝基,调节pH至3~4得到。[2]

4-氨基-3-(4-氟苯基)丁酸
临床资料
其他名称CGP-11130; β-(4-Fluorophenyl)-γ-aminobutyric acid; β-(4-Fluorophenyl)-GABA; Baflofen; Fluorophenibut; F-Phenibut; Fluoribut
给药途径By mouth
识别信息
  • 4-Amino-3-(4-fluorophenyl)butanoic acid
CAS号52237-19-1
PubChem CID
ChemSpider
UNII
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
化学信息
化学式C10H12FNO2
摩尔质量197.21 g·mol−1
3D模型(JSmol英语JSmol
  • C1=CC(=CC=C1C(CC(=O)O)CN)F
  • InChI=1S/C10H12FNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)
  • Key:QWHXHLDNSXLAPX-UHFFFAOYSA-N

立陶宛[3] 和匈牙利[4]的法律将其禁售。

参考文献

编辑
  1. ^ Bowery NG, Hill DR, Hudson AL. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br. J. Pharmacol. 1983, 78 (1): 191–206. PMC 2044790 . PMID 6297646. doi:10.1111/j.1476-5381.1983.tb09380.x. 
  2. ^ Lieuwe Biewenga, Thangavelu Saravanan, Andreas Kunzendorf, Jan-Ytzen van der Meer, Tjaard Pijning, Pieter G. Tepper, Ronald van Merkerk, Simon J. Charnock, Andy-Mark W. H. Thunnissen, Gerrit J. Poelarends. Enantioselective Synthesis of Pharmaceutically Active γ-Aminobutyric Acids Using a Tailor-Made Artificial Michaelase in One-Pot Cascade Reactions. ACS Catalysis. 2019-02-01, 9 (2): 1503–1513 [2021-10-06]. ISSN 2155-5435. PMC 6366683 . PMID 30740262. doi:10.1021/acscatal.8b04299. (原始内容存档于2021-10-06) (英语). 
  3. ^ RINKOS RIBOJIMO PRIEMONĖS FENIBUTUI!. ntakd.lrv.lt. [2020-01-27]. (原始内容存档于2021-10-06) (立陶宛语). 
  4. ^ MAGYARORSZÁG HIVATALOS LAPJA页面存档备份,存于互联网档案馆). Retrieved 2021-04-28.